A BILL 
To direct the Secretary of Health and Human Services, 
acting through the Commissioner of Food and Drugs, 
to establish a competitive grant program under which 
the Secretary will award grants to certain institutions 
to establish American Biopharmaceutical Manufacturing 
Worker Training Centers of Excellence, and for other 
purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Making Essential 
4
Drugs in America Act’’ or the ‘‘MEDS in America Act’’. 
5
23:09 Dec 01, 2021
H5993
2 
•HR 5993 IH
SEC. 
2. 
AMERICAN 
BIOPHARMACEUTICAL 
MANUFAC-
1
TURING WORKER TRAINING CENTERS OF EX-
2
CELLENCE. 
3
(a) IN GENERAL.—The Secretary of Health and 
4
Human Services, acting through the Commissioner of 
5
Food and Drugs, shall establish a competitive grant pro-
6
gram under which the Secretary will award not more than 
7
20 grants to eligible institutions to establish centers of ex-
8
cellence with respect to recruitment and training of bio-
9
pharmaceutical manufacturing workers in the United 
10
States, to be known as ‘‘American Biopharmaceutical 
11
Manufacturing Worker Training Centers of Excellence’’ 
12
(referred to in this section as ‘‘Centers of Excellence’’). 
13
(b) GRANTS.— 
14
(1) AMOUNT.—The amount of a grant under 
15
subsection (a) shall not exceed $1,000,000 per year. 
16
(2) DURATION.—The term of a grant under 
17
this section shall not exceed 5 years. 
18
(3) APPLICATION.—An eligible institution seek-
19
ing a grant under this section shall submit to the 
20
Secretary an application at such time and in such 
21
manner as the Secretary may require that con-
22
tains— 
23
(A) an outline of the institution’s plans to 
24
recruit and train workers who would be pro-
25
ficient in United States biopharmaceutical man-
26
23:09 Dec 01, 2021
H5993
3 
•HR 5993 IH
ufacturing, 
including 
continuous 
manufac-
1
turing, vaccine manufacturing, and working as 
2
sterile operators; and 
3
(B) such other information as the Sec-
4
retary may require. 
5
(c) ELIGIBLE INSTITUTION DEFINED.—In this sec-
6
tion, the term ‘‘eligible institution’’ means an institution 
7
of higher education (as defined in section 101 of the High-
8
er Education Act of 1965 (20 U.S.C. 1001), or an entity 
9
that carries out an apprenticeship registered under the 
10
Act of August 16, 1937 (commonly known as the ‘‘Na-
11
tional Apprenticeship Act’’; 50 Stat. 664, chapter 663; 29 
12
U.S.C. 50 et seq.), which has an established memorandum 
13
of understanding with one or more biopharmaceutical 
14
manufacturers. 
15
(d) TECHNICAL ASSISTANCE.—The Secretary may 
16
provide technical assistance to an eligible institution seek-
17
ing to establish a Center of Excellence, including technical 
18
assistance provided through an advisory committee of the 
19
Food and Drug Administration. 
20
(e) REPORT.—Not later than 2 years after the date 
21
on which the first grant is awarded under this section, 
22
the Comptroller General of the United States shall submit 
23
to Congress a report that— 
24
23:09 Dec 01, 2021
H5993
4 
•HR 5993 IH
(1) assesses the effectiveness of the program es-
1
tablished under this section; and 
2
(2) makes recommendations with respect to ad-
3
ditional measures that may be needed to support 
4
worker training for biopharmaceutical manufac-
5
turing jobs in the United States. 
6
(f) AUTHORIZATION OF APPROPRIATIONS.— 
7
(1) IN GENERAL.—There is authorized to be 
8
appropriated to carry out this section $100,000,000 
9
for the period of fiscal years 2022 through 2026. 
10
(2) RESERVATION
OF
FUNDS
FOR
HISTORI-
11
CALLY
BLACK
COLLEGES
AND
UNIVERSITIES
AND 
12
OTHER
MINORITY-SERVING
INSTITUTIONS.—Of the 
13
amounts made available under paragraph (1) for a 
14
fiscal year, the Secretary shall reserve not less than 
15
20 percent for grants to institutions that are institu-
16
tions of higher education eligible to receive funds 
17
under section 371(a) of the Higher Education Act of 
18
1965 (20 U.S.C. 1067q(a)). 
19
Æ 
23:09 Dec 01, 2021
H5993
